Clonicel FDA Approval Status
FDA Approved: No
Brand name: Clonicel
Generic name: clonidine
Company: Sciele Pharma, Inc. and Addrenex Pharmaceuticals
Treatment for: ADHD
Clonicel is a modified-release clonidine formulation in development to treat attention deficit hyperactivity disorder (ADHD).
Development timeline for Clonicel
| Date | Article |
|---|---|
| Oct 2, 2009 | Sciele Pharma and Addrenex Announce Submission of sNDA to FDA for Clonicel to Treat ADHD |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
